AstraZeneca Slips as Investors Look Ahead to October Results
The shares fell more than major US indexes, while Zacks consensus estimates point to lower quarterly earnings and higher revenue.
Makkler Newsroom · Sep 30, 02:28 AM · 1 min read
Market closed· · GBp · Data may be delayed
Avg. target GBp 16,262.74 (+19.2%)
Prices may be delayed and are for informational purposes only - not investment advice.
The shares fell more than major US indexes, while Zacks consensus estimates point to lower quarterly earnings and higher revenue.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.